UHS director granted 1,217 Class B shares

Nimetz Warren J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Nimetz Warren J. reported acquisition or exercise transactions in this Form 4 filing.

UNIVERSAL HEALTH SERVICES INC director Warren J. Nimetz received an award of 1,217 shares of Class B Common Stock in the form of restricted stock units at no cash cost. The units were granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.

All units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting date. Following this award, Nimetz directly holds 9,698 shares of Class B Common Stock.

Insider Trade Summary

Grant/Award: 1,217 shares

Grant/Award 1 txn

Insider Nimetz Warren J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class B Common Stock	1,217	$0.00	$0.00

Holdings After Transaction: Class B Common Stock — 9,698 shares (Direct)

Footnotes (1)

1. F1. The restricted stock units were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan and all units shall vest on the earlier of May 20, 2027 or the next annual meeting of stockholders which is at least 50 weeks after the 2026 annual meeting date of May 20, 2026.

Key Figures

RSU grant size: 1,217 shares Grant price: $0.0000 per share Post-transaction holdings: 9,698 shares +2 more

5 metrics

RSU grant size 1,217 shares Restricted stock units of Class B Common Stock granted to director

Grant price $0.0000 per share Transaction price per share for the RSU award

Post-transaction holdings 9,698 shares Total Class B Common Stock held directly after the award

Vest date latest May 20, 2027 Latest vesting date for the restricted stock units

Reference meeting date May 20, 2026 Annual meeting date used to define the 50-week vesting condition

Key Terms

restricted stock units, Amended and Restated 2020 Omnibus Stock and Incentive Plan, Class B Common Stock, annual meeting of stockholders

4 terms

restricted stock units financial

"The restricted stock units were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated 2020 Omnibus Stock and Incentive Plan financial

"were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan"

Class B Common Stock financial

"security_title": "Class B Common Stock""

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

annual meeting of stockholders financial

"shall vest on the earlier of May 20, 2027 or the next annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UHS director Warren J. Nimetz report on this Form 4?

Warren J. Nimetz reported receiving 1,217 shares of UHS Class B Common Stock as a restricted stock unit award. The grant was made at no cash cost under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.

When do Warren J. Nimetz’s newly granted UHS restricted stock units vest?

The restricted stock units vest on the earlier of May 20, 2027, or the next annual meeting of UHS stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting date. This creates a time- and service-based vesting schedule.

How many UHS shares does Warren J. Nimetz hold after this Form 4 transaction?

After receiving the 1,217-share award, Warren J. Nimetz directly holds 9,698 shares of UHS Class B Common Stock. This total reflects his position immediately following the reported grant in the Form 4 insider filing.

What plan governs the restricted stock unit award reported by UHS director Warren J. Nimetz?

The award was granted under Universal Health Services, Inc.’s Amended and Restated 2020 Omnibus Stock and Incentive Plan. This plan authorizes equity-based compensation such as restricted stock units for directors, officers, and other eligible participants.

Was Warren J. Nimetz’s UHS stock award a market purchase or a compensation grant?

The transaction was a compensation grant, not a market purchase. It is coded as a grant or award acquisition and carries a transaction price of $0.0000 per share, indicating no cash was paid for the 1,217 restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nimetz Warren J.

(Last) (First) (Middle)

1301 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL HEALTH SERVICES INC [ UHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Common Stock	05/20/2026		A(1)		1,217	A	$0	9,698	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan and all units shall vest on the earlier of May 20, 2027 or the next annual meeting of stockholders which is at least 50 weeks after the 2026 annual meeting date of May 20, 2026.

	/s/ Steve Filton, attorney-in-fact for Mr. Nimetz	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)